首页|温针灸背俞穴对慢性心力衰竭患者的临床疗效及心功能改善情况分析

温针灸背俞穴对慢性心力衰竭患者的临床疗效及心功能改善情况分析

扫码查看
目的 探讨温针灸治疗在慢性心力衰竭患者中的应用效果及其对心脏功能和活动耐受性的改善作用。方法 选取2022年1月—2023年10月福建中医药大学附属康复医院收治的100例慢性心力衰竭患者。通过随机数字表法将患者随机分为对照组与观察组,各50例。对照组仅接受标准药物治疗,观察组在对照组治疗的基础上接受温针灸背俞穴治疗。对比2组患者的治疗效果、心脏功能参数、活动耐力变化、6 min步行距离(six-minute walk distance,6MWD)、血管内皮功能、炎症标志物水平以及不良反应发生率。结果 观察组临床总有效率为96。00%,高于对照组的78。00%,差异有统计学意义(P=0。007)。治疗前,2组左心室收缩末期直径(left ventricular end-systolic dimension,LVESD)、左心室舒张末期直径(left ventricular end-diastolic dimension,LVEDD)以及左心室射血分数(left ventricular ejection fraction,LVEF)比较,差异无统计学意义(P>0。05);治疗后,2组LVEDD、LVESD参数均降低,观察组LVEDD(50。25±2。74)mm、LVESD(45。23±2。79)mm均低于对照组的(54。89±2。87)mm、(53。92±2。77)mm;LVEF参数均上升,观察组[(57。96±6。42)%]高于对照组[(46。22±5。93)%],差异有统计学意义(P<0。05)。治疗前,2组6MWD比较,差异无统计学意义(P>0。05);治疗后,2组6MWD距离均增长,观察组[(347。55±40。72)m]长于对照组[(298。63±32。65)m],差异有统计学意义(P<0。05)。治疗前,2组高敏C反应蛋白(hypersensitive C-reactive protein,hs-CRP)、尿酸(uric acid,UA)、N端脑钠肽前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)指标比较,差异无统计学意义(P>0。05);治疗后,各指标参数均明显降低,观察组hs-CRP(10。06±2。32)mg/L、UA(298。56±30。15)μmol/L、NT-proBNPP(452。23±2。79)ng/L均低于对照组的(15。17±2。96)mg/L、(397。54±32。49)μmol/L、(961。79±2。77)ng/L,差异有统计学意义(P<0。05)。观察组不良反应总发生率为4。00%,低于对照组的20。00%,差异有统计学意义(P<0。05)。结论 在慢性心力衰竭患者的治疗中,温针灸背俞穴的加入可以显著提高治疗效果,改善心脏功能,增强患者的活动耐力,并改善血管内皮功能和炎症标志物水平,同时减少不良反应的发生。
The Clinical Efficacy and Cardiac Function Improvement of Warm Acupuncture at Back Shu Points in Chronic Heart Failure Patients
Objective To evaluate the effect of warm acupuncture treatment in patients with chronic heart failure and its improvement effect on heart function and activity tolerance.Methods A total of 100 patients with chronic heart failure admitted to Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine from January 2022 to October 2023.The patients were randomly divided into the control group and the observation groups,with 50 patients in each group.The control group received only standard medical treatment,while the observation group received warm acupuncture at back shu points on the basis of the treatment of the control group.The treatment effects,cardiac function parameters,changes in activity endurance,6-minute walk distance (6MWD),vascular endothelial function and inflammatory marker levels,and the incidence of adverse effects were compared.Results The overall effective rate of clinical observation group was 96.00%,higher than 78.00% of the control group,with statistically significant differences (P=0.007).Before treatment,there were no statistically significant differences in left ventricular end-systolic dimension (LVESD),left ventricular end-systolic dimension (LVEDD),and left ventricular ejection fraction (LVEF) between the groups (P>0.05).After treatment,LVEDD and LVESD parameters decreased in both groups.The LVEDD (50.25±2.74) mm and LVESD (45.23±2.79) mm of the observation group were lower than (54.89±2.87) mm and (53.92±2.77) mm,respectively.The LVEF parameters all increased,with the observation group[(57.96±6.42)%]being higher than the control group[(46.22±5.93)%],and the difference was statistically significant (P<0.05).Before treatment,there was no statistically significant difference in 6MWD between the two groups (P>0.05).After treatment,the 6MWD distance increased in both groups,with the observation group[(347.55±40.72) m]being longer than the control group[(298.63±32.65) m],and the difference was statistically significant (P<0.05).Before treatment,no statistically significant difference existed in the indicators of hypersensitive C-reactive protein (hs-CRP),uric acid (UA),and N-terminal pro-brain natriuretic peptide (NT-proBNP) between the two groups (P>0.05).After treatment,all indicators parameters were significantly reduced.The hs-CRP (10.06±2.32) mg/L,UA (298.56±30.15) μ mol/L,and NT-proBNP (452.23±2.79) ng/L of the observation group were lower than (15.17±2.96) mg/L,(397.54±32.49)μ mol/L,and (961.79±2.77) ng/L of the control group,respectively,with statistical significance (P<0.05).The total adverse reaction rate of the observation group was 4.00%,which was lower than the control group's 20.00%,and the difference was statistically significant (P<0.05).Conclusion In the treatment of patients with chronic heart failure,the addition of warm acupuncture at back shu points can significantly improve the treatment effect,improve the heart function,enhance the activity endurance of patients,and improve the level of vascular endothelial function and inflammatory markers,while reducing the occurrence of adverse reactions.

chronic heart failurewarm acupuncture at back shu pointscardiac functioncurative effectinflammatory factoradverse reaction

范文曦、邱福山、柯俊华

展开 >

福建中医药大学附属康复医院老年康复科,福建 福州 350003

福建省康复技术重点实验室,福建福州350003

慢性心力衰竭 温针灸背俞穴 心功能 疗效 炎症因子 不良反应

2024

中国卫生标准管理
《中国卫生标准管理》杂志社

中国卫生标准管理

影响因子:1.374
ISSN:1674-9316
年,卷(期):2024.15(21)